Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States
- PMID: 31504302
- PMCID: PMC7384310
- DOI: 10.1093/cid/ciz841
Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States
Abstract
Background: The current opioid injection drug use epidemic has been associated with an increase in hepatitis C virus infections among women of childbearing age in the United States, but changes in hepatitis B virus (HBV) infections have not been studied.
Methods: A retrospective analysis of HBV statuses among women of childbearing age nationally and by state was conducted, utilizing the Quest Diagnostics database. Rates of HBV in women born before and after the implementation of universal HBV vaccination recommendations were determined.
Results: We identified 8 871 965 women tested for HBV from 2011-2017. Nationally, the annual rate of acute HBV infections was stable, but rates increased in Kentucky, Alabama, and Indiana (P < .03). The national prevalence of new, chronic HBV diagnoses decreased significantly, from 0.83% in 2011 to 0.19% in 2017 (P < .0001), but increased in Mississippi, Kentucky, and West Virginia (P ≤ .05). A declining prevalence of HBV seroprotection was evident over time, especially within the birth-dose cohort (which dropped from 48.5% to 38.5%; P < .0001).
Conclusions: National rates of newly diagnosed acute and chronic HBV infections declined or were stable overall, but increased significantly in specific Appalachian states. The HBV vaccine is effective in decreasing infections, but seroprotection wanes over time. These trends in new infections may be related to increased injection drug use and highlight potential gaps in HBV vaccine protection.
Keywords: hepatitis B exposure; hepatitis B vaccination; hepatitis B virus; reproductive age; testing.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures



Similar articles
-
Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.Vaccine. 2017 Aug 16;35(35 Pt B):4515-4522. doi: 10.1016/j.vaccine.2017.07.040. Epub 2017 Jul 21. Vaccine. 2017. PMID: 28736196
-
Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey.Ann Intern Med. 2011 Mar 1;154(5):319-28. doi: 10.7326/0003-4819-154-5-201103010-00006. Ann Intern Med. 2011. PMID: 21357909
-
Increases in Acute Hepatitis B Virus Infections - Kentucky, Tennessee, and West Virginia, 2006-2013.MMWR Morb Mortal Wkly Rep. 2016 Jan 29;65(3):47-50. doi: 10.15585/mmwr.mm6503a2. MMWR Morb Mortal Wkly Rep. 2016. PMID: 26821369
-
Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populations.J Clin Virol. 2006 May;36 Suppl 1:S45-50. doi: 10.1016/s1386-6532(06)80008-9. J Clin Virol. 2006. PMID: 16831693 Review.
-
Epidemiology of hepatitis B in the United States.Hepatology. 2009 May;49(5 Suppl):S28-34. doi: 10.1002/hep.22975. Hepatology. 2009. PMID: 19399791 Free PMC article.
Cited by
-
Hepatitis C is associated with more adverse pregnancy outcomes than hepatitis B: A 7-year national inpatient sample study.Hepatol Commun. 2022 Sep;6(9):2465-2473. doi: 10.1002/hep4.2002. Epub 2022 Jun 24. Hepatol Commun. 2022. PMID: 35748104 Free PMC article.
-
Age-specific seroprotection after Hepatitis B virus vaccination among Korean American pediatric population in Queens, New York.Hum Vaccin Immunother. 2022 Nov 30;18(5):2053404. doi: 10.1080/21645515.2022.2053404. Epub 2022 Apr 4. Hum Vaccin Immunother. 2022. PMID: 35378050 Free PMC article.
-
Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy.Curr Hepatol Rep. 2020 Dec;19(4):345-353. doi: 10.1007/s11901-020-00541-x. Epub 2020 Sep 16. Curr Hepatol Rep. 2020. PMID: 33796434 Free PMC article.
-
Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West Virginia.Am J Prev Med. 2020 Nov;59(5):e189-e196. doi: 10.1016/j.amepre.2020.05.022. Epub 2020 Oct 1. Am J Prev Med. 2020. PMID: 33012623 Free PMC article.
-
Exploring blood lipids-immunity associations following HBV vaccination: evidence from a large cross-sectional study.Front Cell Infect Microbiol. 2024 Mar 8;14:1369661. doi: 10.3389/fcimb.2024.1369661. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38524185 Free PMC article.
References
-
- Ly KN, Jiles RB, Teshale EH, Foster MA, Pesano RL, Holmberg SD. Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014. Ann Intern Med 2017; 166:775–82. - PubMed
-
- Koneru A, Nelson N, Hariri S, et al. . Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission - United States and Kentucky, 2011-2014. MMWR Morb Mortal Wkly Rep 2016; 65:705–10. - PubMed
-
- Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014; 384:2053–63. - PubMed
-
- Harris AM, Iqbal K, Schillie S, et al. . Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006-2013. MMWR Morb Mortal Wkly Rep 2016; 65:47–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical